Search

Your search keyword '"Marlies Ostermann"' showing total 236 results

Search Constraints

Start Over You searched for: Author "Marlies Ostermann" Remove constraint Author: "Marlies Ostermann" Language undetermined Remove constraint Language: undetermined
236 results on '"Marlies Ostermann"'

Search Results

3. Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup

6. Indications for and Timing of Initiation of KRT

7. The Effect of an Accelerated Renal Replacement Therapy Initiation Is Not Modified by Baseline Risk

10. ICU without borders

11. Novel Anemia Therapies in CKD: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

12. Relationship between D-dimers and dead-space on disease severity and mortality in COVID-19 acute respiratory distress syndrome: A retrospective observational cohort study

13. The Role of Cell Cycle Arrest Biomarkers for Predicting Acute Kidney Injury in Critically Ill COVID-19 Patients: A Multicenter, Observational Study

14. Diuretics and ultrafiltration in heart failure

16. Contributors

19. Changing epidemiology of acute kidney injury in critically ill patients with COVID-19: a prospective cohort

20. Pathophysiology of fluid administration in critically ill patients

21. Acute kidney injury

22. Definitions of acute renal dysfunction: an evolving clinical and biomarker paradigm

23. Почечная ассоциация. Клинические руководства по острому поражению почек (ОПП), август 2019

24. Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference

25. Biomarker-Based Management of AKI: Fact or Fantasy?

26. Integration of Equipoise into Eligibility Criteria in the STARRT-AKI Trial

28. New drugs for acute kidney injury

29. Consensus-Based Recommendations on Priority Activities to Address Acute Kidney Injury in Children: A Modified Delphi Consensus Statement

30. Prevention of Cardiac Surgery–Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial

31. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

32. Nutritional assessment and support during continuous renal replacement therapy

33. Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care

35. Review of Anti-inflammatory and Antiviral Therapeutics for Hospitalized Patients Infected with Severe Acute Respiratory Syndrome Coronavirus 2

37. Outcomes of critically ill COVID-19 patients managed in a high-volume severe respiratory failure and ECMO centre in the United Kingdom

38. How can assessing hemodynamics help to assess volume status?

39. Pro: We Should Stop ACE Inhibitors Early Before Cardiac Surgery to Prevent Postoperative Acute Kidney Injury

40. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury

41. Fluid management knowledge in hospital physicians: ‘Greenshoots’ of improvement but still a cause for concern

42. A Multinational Observational Study Exploring Adherence With the Kidney Disease

43. Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study

44. Acute kidney injury as a risk factor of hyperactive delirium: A case control study

45. Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study

46. Predictive Models for Acute Kidney Injury Following Cardiac Surgery: The Importance of Accurate and Actionable Prediction

47. Ten myths about albumin

48. Occurrence and Risk Factors for New Dependency on Chronic Care, Respiratory Support, Dialysis and Mortality in the First Year After Sepsis

49. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

50. Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer

Catalog

Books, media, physical & digital resources